No Data
No Data
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Piper Sandler Maintains Accolade(ACCD.US) With Hold Rating, Maintains Target Price $7.03
Piper Sandler Downgrades Accolade(ACCD.US) to Hold Rating, Cuts Target Price to $7.03
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Press Release: Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction